PEPTOKING
EN

All peptides

49 peptides, from licensed medicines to research chemicals. Filter by what they do, whether they are approved, and how well they are studied.

49 peptides

  1. ApprovedAbaloparatideParathyroid hormone-related protein (PTHrP) analogue (bone-building agent)34
  2. ApprovedAfamelanotideMelanocortin 1 receptor (MC1R) agonist13
  3. In clinical trialsAmycretinUnimolecular GLP-1 and amylin receptor agonistNo single sequence68 WADA banned
  4. Not approvedAOD-9604Modified growth hormone fragment (research peptide)16 WADA banned
  5. Cosmetic ingredientArgirelineSNARE-modulating hexapeptide (cosmetic ingredient)6
  6. Not approvedBPC-157Synthetic gastric pentadecapeptide (research chemical)15 WADA banned
  7. ApprovedBremelanotideMelanocortin receptor agonist7
  8. In clinical trialsCagrilintideLong-acting amylin analog (amylin and calcitonin receptor agonist)37 WADA banned
  9. Approved elsewhereCerebrolysinMixture of low molecular weight peptides and free amino acids derived from porcine brainNo single sequence·
  10. Not approvedCJC-1295Long-acting GHRH analogue (research peptide)30 WADA banned
  11. Not approvedCollagen peptidesHydrolysed collagen (food supplement)No single sequence·
  12. Not approvedDelta sleep-inducing peptideNonapeptide of uncertain physiological role, first described as a sleep factor9 WADA banned
  13. Not approvedDihexaAngiotensin IV derived dipeptide mimetic, described as a hepatocyte growth factor (HGF) and c-Met potentiator2 WADA banned
  14. ApprovedDulaglutideGLP-1 receptor agonist (Fc fusion protein)31
  15. ApprovedElamipretideMitochondria-targeted cardiolipin-binding tetrapeptide4
  16. Not approvedEpitalonSynthetic pineal tetrapeptide (geroprotector candidate)4 WADA banned
  17. ApprovedExenatideGLP-1 receptor agonist39
  18. Not approvedFOXO4-DRID-retro-inverso cell-penetrating peptide that blocks the FOXO4 and p53 interaction (senolytic)46 WADA banned
  19. Cosmetic ingredientGHK-CuCopper-binding tripeptide (cosmetic ingredient)3
  20. Not approvedGHRP-6Growth hormone secretagogue (ghrelin receptor agonist)6 WADA banned
  21. ApprovedGonadorelinGonadotrophin-releasing hormone (synthetic GnRH)10 WADA banned
  22. ApprovedInsulin (human)Peptide hormone (insulin)51 WADA banned
  23. Not approvedIpamorelinGrowth hormone secretagogue (ghrelin receptor agonist)5 WADA banned
  24. In clinical trialsKisspeptinKISS1 receptor (GPR54) agonist, natural neuropeptide54 WADA banned
  25. Not approvedKPVAlpha-MSH-derived tripeptide (research chemical)3 WADA banned
  26. ApprovedLeuprolideGnRH receptor agonist9 WADA banned
  27. ApprovedLinaclotideGuanylate cyclase-C agonist14
  28. ApprovedLiraglutideGLP-1 receptor agonist31
  29. Not approvedLL-37Human cathelicidin antimicrobial peptide37 WADA banned
  30. Approved elsewhereMazdutideGlucagon and GLP-1 receptor dual agonist (oxyntomodulin analog)34
  31. Not approvedMelanotan IINon-selective melanocortin receptor agonist (research peptide)7 WADA banned
  32. Not approvedMOTS-cMitochondrial-derived peptide (research peptide)16 WADA banned
  33. ApprovedOxytocinOxytocin receptor agonist (posterior pituitary hormone)9
  34. Cosmetic ingredientPalmitoyl pentapeptide-4Signal peptide (cosmetic ingredient)5
  35. WithdrawnPramlintideAmylin analog37
  36. In clinical trialsRetatrutideGIP, GLP-1 and glucagon receptor triple agonist39 WADA banned
  37. Approved elsewhereSelankTuftsin analogue heptapeptide (peptide anxiolytic)7
  38. ApprovedSemaglutideGLP-1 receptor agonist31
  39. Approved elsewhereSemaxACTH(4-10) fragment analogue (melanocortin-derived neuropeptide)7
  40. WithdrawnSermorelinGrowth hormone-releasing hormone (GHRH) analogue29 WADA banned
  41. ApprovedSetmelanotideMelanocortin-4 receptor (MC4R) agonist8
  42. In clinical trialsSurvodutideGlucagon and GLP-1 receptor dual agonist29 WADA banned
  43. Not approvedTB-500Thymosin beta-4 fragment (research chemical)7 WADA banned
  44. ApprovedTeduglutideGLP-2 analogue33
  45. ApprovedTeriparatideParathyroid hormone analogue (bone-building agent)34
  46. ApprovedTesamorelinGrowth hormone-releasing factor (GHRF) analogue44 WADA banned
  47. Approved elsewhereThymosin alpha-1Thymic peptide immunomodulator28
  48. ApprovedTirzepatideDual GIP and GLP-1 receptor agonist39
  49. ApprovedVosoritideC-type natriuretic peptide (CNP) analogue39